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Background/aim: Evaluate the risk factors associated with pseudoaneurysms' development after the percutaneous interventional procedures
performed by cardiology, interventional radiology (IR), and the other clinics.
Materials and methods: We retrospectively analyzed the ultrasound scans in the hospital database and picture archiving system (PACS) and
enrolled a total of 132 patients during the period from October 2015 and December 2019. We evaluated the maximum diameter and volume
of the pseudoaneurysm with the patient and procedure-related factors with univariate analysis.
Results: We found that the patients with hypertension and without peripheric artery disease (PAD) had greater sac diameter (p = 0.010 and p
= 0.016) and increased sac volume (p = 0.029 and p = 0.007). However, the sac volume increased in patients with diabetes than those without
(p = 0.003). Both the increased maximum diameter and the volume of the pseudoaneurysm sac were in the patients in whom the procedure
was applied in the common femoral artery (CFA) and with the venous intervention (p < 0.010 and p < 0.016; p = 0.004 and p = 0.001,
respectively). We found that platelet count correlated negatively with the sac's maximum diameter and the volume (r = –0.383, p < 0.001 and r
= –0.486, p < 0.001, respectively) duration of intervention correlated positively with the sac's maximum diameter and the volume (r = 0.205, p
= 0.019 and r = 0.320, p < 0.001).
Conclusion: Our study reveals that prolonged procedure duration, simultaneous arterial and venous accesses, peripheral artery disease,
thrombocytopenia, and puncture site are the aggressive risk factors of pseudoaneurysms size after angiographic procedures.
Key words: Pseudoaneurysm, hematoma, vascular complication, angiography

1. Introduction
Pseudoaneurysms are one of the most common complications
resulting from percutaneous vascular interventions.
Pseudoaneurysms develop in 2% of diagnostic procedures
and 6% of those performed for therapeutic purposes [1–3].
With pseudoaneurysms, other local complications, including
arteriovenous fistula, hematoma, and dissection, have been
reported to occur in 1%–6% of percutaneous vascular
interventions [4]. The femoral artery is a widely preferred
approach among the endovascular diagnostic and
interventional procedures, although the radial artery route
has been increasingly used due to lower complication rates
[5,6].
Several patient or procedure-related factors have been
identified as leading causes of complications of
pseudoaneurysms. Patient-related factors include mainly high
body mass index, female sex, low pre-procedural platelet
counts, and procedure-related factors with the urgency of
intervention, site of the procedure, and size of the sheath [7].
Several treatment options have been identified for the
management of vascular intervention-related complications.
US-guided compression is a standard post-interventional
procedure used throughout the last three decades, and

noticeably reduced the need for surgical treatments of
pseudoaneurysms. The technique is performed by placement
and compression of the US probe to eliminate the flow on the
pseudoaneurysm's neck with an average compression time of
nearly thirty minutes [7]. US-guided percutaneous thrombin
injection is one of the techniques to manage the
pseudoaneurysm successfully [8–10]. For the large
hematomas, which cause impending skin necrosis, infection,
or in the case of a concomitant arteriovenous fistula, surgery
is a treatment option [11,12].
This study's objective was to evaluate the risk factors
arising from the method, the practitioner, the application
reasons, or the patient-related pre-application situations.
2. Materials and methods
2.1. Patients
Using a retrospective hospital database and picture archiving
system (PACS), we identified 132 patients, for whom a lower
extremity arterial doppler ultrasound examination was
performed between October 2015 and December 2019 to rule
out extremity vascular access after an arterial puncture. We
identified the search items as "pseudoaneurysm,"
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"hematoma," "loculated fluid collection." We excluded the
pseudoaneurysms and interventions of viscera, carotid artery,
and branches and identified the patient with diagnosedtreated with US-guided compression, US-guided thrombin
injection, endovascular stent, or surgical repair. We excluded
the patients with the infected pseudoaneurysm, distal
ischemia due to femoral pseudoaneurysm compression, or
impending
compartment
syndrome,
spontaneous
thrombosed aneurysms from the study.
We retracted the data related to the sac size and volume
from imaging reports and related to the procedure (puncture
side, sheath size, synchronic vein cannulation), duration and
types of the processes [coronary stent, transcutaneous aortic
valve implantation (TAVI), diagnostic], practitioner
[cardiologist, interventional radiologist (IR) and others] or
treatment methods of the pseudoaneurysm (compression,
thrombin injection, surgery) from the radiology records. The
treatment of lower extremity pseudoaneurysms was
spontaneous thrombosis of the aneurysm, ultrasound-guided
compression therapy, ultrasound-guided thrombin injection,
or surgery. We obtained patient's chronic diseases
[hypertension (HT), diabetes mellitus (DM), peripheric artery
disease], pre-procedure medications (anticoagulants,
antiaggregants), smoking, laboratory results before
pseudoaneurysm treatment (hemoglobin, platelet count, INR,
puncture side, sheath size, synchronic vein cannulation) from
the hospital digital recording system.
We documented the maximum diameter of
pseudoaneurysm on three dimensions as length, height, and
width. We calculated the pseudoaneurysm volume by
multiplying these three measures with a coefficient (length ×
height × width × 0.52) as shown in Figures 1 and 2.
This retrospective study was approved by the local
Institutional Review Board approval with the approval

number of KU GOKAEK 2019/229 and did not require
written informed consent.

Figure 1. B-mode ultrasound image showing partially
thrombosed pseudoaneurysm (white arrow) of the right common
femoral artery (black arrow).

Figure 2. Color-coded duplex ultrasound image showing partially
thrombosed pseudoaneurysm (white arrow) of the right common
femoral artery (black arrow). The characteristic swirling blood
flow sign ("yin-yang" sign) is marked with a white star.
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2.2. Statistical analysis
The descriptive statistics for clinical and demographic
characteristics of the patients were presented as frequency and
percentage (%) for categorical variables and median with
interquartile range (median [Q3–Q1]) or mean with standard
deviation according to the distribution of the continuous
variables. The normality was assessed both visually and
through the Shapiro–Wilk test. Mann–Whitney U test
(Wilcoxon rank-sum test) was used for parameters that were
not normally distributed to evaluate the intergroup
differences between two independent groups and Kruskal–
Wallis test for more groups. Dunn's pairwise tests were
carried out with post hoc analysis using the Mann–Whitney
U test. The p value was adjusted using the Bonferroni
correction. We used Spearman's rank correlation coefficients
to examine the degree of associations between the maximum
diameter and the volume of the pseudoaneurysm sac and
patient and procedure-related risk variables.
We performed statistical analyses by using the "SPSS v:
20.0 software package" (IBM Inc., Chicago, IL, USA) and
RStudio (v: 1.2.1335 2009-2019 RStudio, Inc). Two-sided p
values less than 0.05 were considered statistically significant
(p < 0.05).
3. Results
All patients were aged 58 years or older, and sex distribution
was approximately equal. Nearly two-thirds of patients had
diabetes, whereas only around 40% had hypertension or PAD,
and fewer than a third had a history of smoking. More than
half had not had any form of pre-intervention treatment, and
the remainder was divided among and range of antiplatelet
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and anticoagulant therapies, as shown in Table 1. More than
two-thirds of procedures were carried out in the cardiology
specialty, with the remainder taking place in interventional
radiology. The data related to the characteristics of
pseudoaneurysm,
and the
process applied for
pseudoaneurysm in Table 2. The maximum diameter and
volume of the pseudoaneurysm's sac were about 50 mm and
35 mm3, respectively. Nearly half of (47.7%) of the procedures
were performed using a sheath with a size of 6 Fr (6.28 mm).
Most of the pseudoaneurysm developed after the
angiographic procedures for any reason (46.4%). In 38.6% of
the patients, the pseudoaneurysm was treated with only
ultrasound-guided thrombin injection, and 9.1% required
open surgical repair.
We analyzed the change in the maximum diameter and
the volume of the pseudoaneurysm sac due to patient and
procedure-related risk factors. We found that the patients
with hypertension and without peripheric artery disease
(PAD) had greater sac diameter (p = 0.010 and p = 0.016,
respectively) and increased sac volume (p = 0.029 and p =
0.007, respectively). However, the sac volume was increased
in patients with diabetes than those without (p = 0.003).
The pseudoaneurysm maximum diameter and volume
were higher in patients who underwent treatment with the
synchronous common femoral artery (CFA) and common
femoral vein (CFV) catheterization (p < 0.010 and p < 0.016;
p = 0.004 and p = 0.001 respectively) (Table 3).

We evaluated the correlation between the maximum
diameter and the volume of the pseudoaneurysm sac and
patient-related and procedure risk variables. We found that
platelet count correlated negatively with the sac's maximum
diameter and the volume (r = -0.383, p < 0.001 and r = -0.486,
p < 0.001, respectively); duration of intervention correlated
negatively with the sac's maximum diameter and the volume
(r = 0.205, p = 0.019 and r = 0.320, p < 0.001, respectively)
(Table 4). When the sac's maximum diameter and the volume
were compared across the pre-intervention treatment and
sheath size, there was a significant difference between the
treatment groups. The pairwise comparison revealed that the
difference resulted from the dual antiplatelet and monoantiplatelet treatment groups (p = 0.002). The sac's maximum
Table 2. Characteristics of pseudoaneurysm and procedure
characteristics for pseudoaneurysm intervention.
N = 132
Diameter of pseudoaneurysm, mm, [Q1–Q3]
3

Volume of the pseudoaneurysm, mm , [Q1–Q3]

50 [40–59]
35 [13–77]

Sheath size
5 Fr (5.24 mm), n (%)

56 (42.4%)

6 Fr (6.28 mm), n (%)

63 (47.7%)

7 Fr (7.33 mm), n (%)

6

(4.5%)

8 Fr (8.34 mm), n (%)

6

(4.5%)

Unknown, n (%)

1

(0.8%)

Duration of intervention, min, [Q1–Q3]

25 [11–45]

Table 1. Patient characteristics and drug regimens before
pseudoaneurysm intervention.
N = 132

Site of pseudoaneurysm (CFA), n (%)

76 (57.6%)

Age (years), median [Q1–Q3]

67

(58–74)

Coronary angioplasty with stent insertion, n (%)

21 (15.9%)

Female, n (%)

69

(51.9)

Endocardial ablation, n (%)

10 (7.6%)

Diabetes mellitus, n (%)

82

(61.7)

Transcutaneous aortic valve implantation, n (%)

9

(6.8%)

Hypertension, n (%)

56

(42.1)

Pacemaker insertion, n (%)

3

(2.3%)

Peripheric artery disease (PAD), n (%)

50

(37.6)

Vascular interventional radiology

Smoking, n (%)

42

(31.6)

Angioplasty (any vessel), n (%)

3

(2.3%)

Hemoglobin (g/L), median [Q1-Q3]

11.2

(10.4–12.7)

Platelet count (x109/L), median [Q1–Q3]

Aneurism repair, n (%)

9

(6.8%)

204

(121–480)

Stent insertion (any vessel), n (%)

18 (13.6%)

INR, median (Q1–Q3)

1.13

(1.01–1.55)

Other

None, n (%)

75

(55.6)

Treatment of pseudoaneurysm

Acetylsalicylic acid, n (%)

39

(29.5)

Compression only, n (%)

42 (31.8%)

Clopidogrel, n (%)

34

(25.8)

Thrombin injection only, n (%)

51 (38.6%)

Warfarin, n (%)

21

(15.9)

Compression + Tissel, n (%)

39 (29.5%)

Antiplatelet mono-therapy, n (%)

10

(7.6)

Thrombin injection number

Antiplatelet dual-therapy, n (%)

28

(21.2)

None, n (%)

51 (38.6%)

Anticoagulant mono-therapy, n (%)

16

(12.1)

Once, n (%)

70 (53%)

Anticoagulant + mono-antiplatelet, n (%)

5

(3.8)

Cardiology, n (%)

92

(69.6)

IR, n (%)

40

(30.4)

Twice, n (%)
11 (8.3%)
Compression duration (for successful), min, [Q120 [15–25]
Q3]
Open surgical repair, n (%)
12 (9.1%)

Pre-intervention treatment

Causative procedure
Cardiology

Angiography (any vessel), n (%)

Specialty performing procedure

56 (42.4%)
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Table 3. The change in maximum diameter and the volume of the pseudoaneurysm sac between patient-related risk variables, procedure,
and aneurysm related risk characteristics.
Maximum diameter
Volume
P
P
(Mm)
(mm3)
Female
51[34–66]
0.571
34 [11.3–84.8]
0.823
Male

49 [41–59]

Hypertension
Diabetes
PAD
Smoking
Hematoma

(yes)

51 [41–66]

(no)

40 [33–59]

(yes)

50 [47–66]

(no)

48 [34–59]

(yes)

46 [34–56]

(no)

55 [40–66]

(yes)

50 [47–59.5]

(no)

49 [34–59]

(yes)

50 [50–62.5]

(no)

49 [34–59]

Cardiology

49 [40–59]

IR

50 [34–57]

CFA

40 [33–53.5]

SFA

0.010*

Operation

(yes)

59 [49–66]

(no)

48.5 [33.8–59]

(yes)

44.5 [22.5–68]

(no)

50 [40–59]

Table 4. Correlation between the in maximum diameter and the
volume of the pseudoaneurysm sac and patient-related and
procedure risk variables.
Maximum
Volume
diameter
r
p
r
p
Age

0.075

0.391

–0.057

0.519

Haemoglobin

0.159

0.068

0.231

0.008*

Platelet count

–0.383

<0.001*

–0.486

<0.001*

–0.061

0.489

0.320

<0.001*

0.063

0.472

INR
–0.112 0.201
Duration of
0.205
0.019*
intervention
Duration of
0.127
0.148
compression
INR, international normalized ratio.

diameter and volume were greater with larger sheath size. We
analyzed the sac's maximum diameter and volume in terms of
post-intervention treatment and the intervention reason. The
maximum diameter of the sac did not influence the decision
of the post-intervention treatment. However, ultrasoundguided compression repair (UGCR) + ultrasound-guided
thrombin injection (UGTI) was preferred more compared to
UGTI alone (p = 0.007). Cryoablation and cardiac stent
caused greater sac volume and max diameter than the
imaging/diagnostic group (p = 0.001 and p < 0.001,
respectively).

39 [13–83]

0.029*

18 [13–66.5]
0.056

50 [13–92]

0.003*

22 [13–62]
0.016*

22 [12–50]

0.007*

45 [18-83]
0.342

43 [18–67]

0.279

22 [12.8–79]
0.179

22 [12–86.5]

0.529

37 [13–71]
0.804

41 [14–74.8]

0.193

34.5 [12–82]
<0.001*

59 [50–70]

Venous intervention
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39 [14–71]

41 [14–74.8]

<0.001*

34.5 [12–82]
0.004*

71 [41–83]

0.001*

22 [12–67]
0.475

23.5 [9.25–61.8]

0.154

38 [13–78.8]

4. Discussion
Clinical assessment of vascular access is related to identifying
pseudoaneurysm and its risk factors. We obtained several
modifiable factors after percutaneous vascular interventions
in a large cohort of patients in our study.
Our results revealed that HT, DM, and PAD were related
to increased sac diameter and volume of the pseudoaneurysm
in accordance with the literature [13–15]. Our results revealed
that the size and volume of pseudoaneurysm were related to
synchronous arterial and venous catheterization that has not
been reported previously by a study in the literature. We
considered this result linked to the synchronous arterial and
venous catheterization procedure performed by cardiologists
for TAVI and pacemaker applications, which require devices
and stents with larger-bore and longer sheaths, prolonged
procedure duration, and perioperative anticoagulation [12].
The most common puncture site of peripheral
pseudoaneurysms was CFA in our study, as stated in the
literature's most frequent location [16–18]. Compared to SFA,
our results showed that the pseudoaneurysm' size and volume
were more significant in CFA. The possible explanation for
this result may be that the cohort included procedures
performed mainly by radiologists in our study. They were
related to broader sized access and longer procedure duration
than the other coronary angiography and intracardiac device
implantation interventions. This result may be a point of
interest to other studies because it has never been reported.
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The prolonged procedure duration is a significant risk
factor, and the correlation between prolonged duration and
size-volume of aneurysm sac was found statistically
significant in our study. In the only study of Badr et al.,
prolonged procedure duration was not associated with the
increased aneurysm size in the literature other than ours [15].
In our study, the size and volume of the pseudoaneurysm were
evaluated with prolonged procedure time, whereas in the
studies of Badr et al., only the size was assessed. Prolonged
procedure time may require more time for sheath removing
in the artery, cause more vascular endothelium damage, and
need more anticoagulants in the procedure such as stents.
Our study also demonstrated that thrombocytopenia was
a significant and independent risk factor of pseudoaneurysm
after arterial catheterization. Our result showed a significant
correlation between the thrombocyte count and the sizevolume of the pseudoaneurysm. In the literature, the
correlation between the occurrence-recurrence of
pseudoaneurysm after arterial catheterization and platelet
count under a cut-of 200 × 10⁹/L level is well-known [19,20].
However, our study showed a relationship between the overall
platelet count and pseudoaneurysm's diameter and volume.
Anticoagulant and antiplatelet drug regimens before
vascular procedures are modifiable risk factors. Medications
used as a standard practice to prevent thromboembolic
complication after any large-sized sheath in any artery
accesses has been identified as a common risk factor for
pseudoaneurysm [12]. We showed a significant change in sac
volume and maximum diameter across the pre-procedure
treatment groups. However, this result was due to the
increased volume and diameter in patients under mono
antiplatelet compared to dual mono antiplatelet therapy. This
unexpected result may be explained by the high number of
patients in the monotherapy group.
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